A ‘mix and match’ approach to SARS-CoV-2 vaccination

被引：0
作者：
Meagan E. Deming
Kirsten E. Lyke
机构：
[1] University of Maryland School of Medicine,The Center for Vaccine Development and Global Health
来源：
Nature Medicine | 2021年 / 27卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Heterologous dosing with the adenovirus-based ChAdOx1 (AstraZeneca) vaccine followed by an mRNA vaccine induced stronger immune responses than did the homologous ChAdOx1 vaccine series, according to recent immunogenicity studies.
引用
收藏
页码：1510 / 1511
页数：1
相关论文
共 13 条
  • [1] Wise J(2021)undefined Br. Med. J. 372 n699-130
  • [2] Barros-Martins J(2021)undefined Nat. Med. 398 121-488
  • [3] Borobia AM(2021)undefined Lancet 396 479-897
  • [4] Zhu F(2020)undefined Lancet 396 887-423
  • [5] Logunov DY(2020)undefined Lancet 34 413-1468
  • [6] Cucchiari D(2021)undefined Am. J. Transplant. 12 1466-1898
  • [7] Kardani K(2016)undefined Vaccine 384 1885-undefined
  • [8] Bolhassani A(2021)undefined Nat. Commun. 384 undefined-undefined
  • [9] Shahbazi S(2021)undefined N. Engl. J. Med. undefined undefined-undefined
  • [10] Spencer AJ(2021)undefined N. Engl. J. Med. undefined undefined-undefined
12